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Abstract. 
 
Tight junctions (TJ) govern ion and solute 
diffusion through the paracellular space (gate func-
tion), and restrict mixing of membrane proteins and lip-
ids between membrane domains (fence function) of po-
larized epithelial cells. We examined roles of the RhoA 
and Rac1 GTPases in regulating TJ structure and func-
tion in MDCK cells using the tetracycline repressible 
transactivator to regulate RhoAV14, RhoAN19, 
Rac1V12, and Rac1N17 expression. Both constitutively 
active and dominant negative RhoA or Rac1 perturbed 
TJ gate function (transepithelial electrical resistance, 
tracer diffusion) in a dose-dependent and reversible 
manner. Freeze-fracture EM and immunofluoresence 
microscopy revealed abnormal TJ strand morphology 
and protein (occludin, ZO-1) localization in RhoAV14 
and Rac1V12 cells. However, TJ strand morphology 
and protein localization appeared normal in RhoAN19 
and Rac1N17 cells. All mutant GTPases disrupted the 
fence function of the TJ (interdomain diffusion of a flu-
orescent lipid), but targeting and organization of a 
membrane protein in the apical membrane were unaf-
fected. Expression levels and protein complexes of oc-
cludin and ZO-1 appeared normal in all mutant cells, 
although ZO-1 was more readily solubilized from 
RhoAV14-expressing cells with Triton X-100. These re-
sults show that RhoA and Rac1 regulate gate and fence 
functions of the TJ, and play a role in the spatial organi-
zation of TJ proteins at the apex of the lateral mem-
brane.
Key words: GTPase • RhoA • epithelial cells • tight 
junction • polarity
 
E
 
pithelia
 
 form barriers and regulate vectorial trans-
port of ions and solutes between different biologi-
cal compartments separated by these barriers,
thereby contributing to the maintenance of homeostasis
(Almers and Stirling, 1984). Two key structural features of
transporting epithelial cells specify this function: restricted
distributions of specific membrane proteins to functionally
distinct membrane domains that face these compartments
(Rodriguez-Boulan and Nelson, 1989), and formation of
an intercellular junctional complex (Farquhar and Palade,
1963). The tight junction (TJ),
 
1
 
 the most apical structure of
the junctional complex, acts as a selective permeability
barrier to the paracellular space (gate function; Diamond,
1977), and an intramembranous fence to prevent free mix-
ing of membrane domain-specific proteins and lipids
(fence function; Dragsten et al., 1981; van Meer et al.,
1986; van Meer and Simons, 1986).
The TJ has a well-described but poorly understood
structure. Freeze-fracture EM has depicted the TJ as a
continuous network of parallel and interconnected strands
that circumscribe the apex of lateral membranes of adja-
cent cells (Claude, 1978). Early studies sought to establish
a relationship between TJ strand number and function
(Claude, 1978), but it has been difficult to extrapolate gen-
eralizations to all cell types (Stevenson et al., 1988). Little
is known about how TJ functions are regulated in different
physiological or pathological conditions, or about the mo-
lecular basis for differences in the paracellular permeabil-
ity of leaky (e.g., proximal renal tubule) and tight epithelia
(e.g., distal renal tubule).
The protein composition and organization of TJ are be-
ing uncovered. Occludin is the only TJ transmembrane
protein identified so far (Furuse et al., 1993). Immunoelec-
tron microscopy combined with freeze fracture has shown
that occludin is localized to TJ strands (Fujimoto, 1995).
Overexpressing full-length occludin or mutant occludin
lacking the cytoplasmic domain (Balda et al., 1996; Mc-
Carthy et al., 1996), or adding a synthetic peptide corre-
sponding to the second extracellular loop of occludin
(Wong and Gumbiner, 1997) perturb TJ gate function.
However, recent evidence from transgenic ablation of the
 
Address all correspondence to W. James Nelson, Department of Molecu-
lar and Cellular Physiology, Stanford University School of Medicine,
Beckman Center, B121, Stanford, CA 94305-5345. Tel.: 650-725-7596;
Fax: 650-498-5286; E-mail: wjnelson@leland.stanford.edu
 
1. 
 
Abbreviations used in this paper
 
: DC, doxycycline; TER, transepithelial
electrical resistance;
 
 
 
TJ, tight junctions.
  
The Journal of Cell Biology, Volume 142, 1998 102
 
occludin gene indicates that occludin is not required for TJ
gate function (Saitou et al., 1998). Note, however, that ec-
topic expression of occludin in fibroblasts confers cell–cell
adhesion, indicating that occludin has some adhesive func-
tion in TJ organization (van Itallie and Anderson, 1997).
Several cytoplasmic proteins interact either directly or
indirectly with occludin, including ZO-1 and ZO-2 (Itoh
et al., 1993; Willott et al., 1993; Jesaitis and Goodenough,
1994; Furuse et al., 1994). These proteins may act as a pro-
tein scaffold to organize occludin at the TJ. For example,
the spatial organization of occludin on the membrane of fi-
broblasts requires coexpression of ZO-1 (van Itallie and
Anderson, 1997). ZO-1 and ZO-2 also contain PDZ do-
main and SH3 domains (Fanning and Anderson, 1996;
Itoh et al., 1993; Jesaitis and Goodenough, 1994; Songyang
et al., 1997; Willott et al., 1993), and may recruit signaling
molecules and the actin cytoskeleton to the TJ.
A number of signaling molecules have been implicated
in the regulation of TJ function, including tyrosine kinases,
cAMP, Ca
 
2
 
1
 
, protein kinase C, heterotrimeric G proteins,
and phospholipase C (Anderson and van Itallie, 1995;
Cereijido et al., 1993). Two targets common to these mole-
cules are actin (Anderson and van Itallie, 1995) and the
perijunctional actin–myosin ring located subjacent to the
apical junction complex (Madara, 1988). It has been pro-
posed that contraction of peri-junctional actin filaments
and the resulting centrifugal traction on TJ membrane reg-
ulates TJ permeability (Madara et al., 1988).
Signaling molecules that directly control actin cytoskele-
ton organization are particularly intriguing with regard to
TJ function regulation. The family of Ras-related small
GTP-binding proteins RhoA, Rac1, and Cdc42 are regula-
tors of the actin cytoskeleton (Hall, 1998). Microinjection
of RhoA, Rac1, or Cdc42 induces stress fiber formation,
membrane ruffling, and extension of filopodia, respec-
tively, in serum-starved Swiss 3T3 fibroblasts (Ridley and
Hall, 1992; Ridley et al., 1992). Recent studies have impli-
cated RhoA GTPases in TJ functions. Nusrat et al. (1995)
found that the organization of the perijunctional actin cy-
toskeleton and ZO-1 were disrupted after exposing T84
cells to recombinant 
 
Clostridium botulinum
 
 exotoxin C3,
which ADP-ribosylates Rho family proteins and disrupts
their functions (Aktories, et al., 1989; Sekine et al., 1989).
Concomitantly, the TJ gate function was disturbed. Nusrat
et al. (1995) also transiently expressed RhoC in T84 cells
and observed a condensation of actin filament at cell–cell
contact sites, but a functional analysis of TJ was not re-
ported. Takaishi et al. (1997) examined MDCK cells con-
stitutively expressing RhoA mutant genes, and reported
no effect on the TJ morphology at steady state except dur-
ing PKC-induced TJ assembly in the presence of low ex-
tracellular calcium concentrations, but they did not per-
form ultrastructural or functional analyses of the TJ.
To study roles of RhoA and Rac1 in the structural and
functional organization of TJ, we generated MDCK cells
that express RhoA and Rac1 mutants under the control of
the tetracycline repressible transactivator (Gossen and
Bujard, 1992). As shown in the preceding study (Jou and
Nelson, 1998), this system has advantages over constitu-
tive gene expression and protein microinjection. Func-
tional analysis of TJ in these mutants revealed that the
gate function was disrupted upon expression of RhoA and
 
Rac1 mutants in a dose-dependent and reversible manner.
Constitutively active RhoA and Rac1 mutants induced a
dramatic disorganization of TJ strands and protein (occlu-
din, ZO-1, actin) distribution, while dominant negative
RhoA and Rac1 mutants affected neither TJ morphology
nor TJ protein distribution. All mutants disrupted TJ
fence function, as determined by interdomain diffusion of
a fluorescent membrane lipid, but targeted delivery and
membranous distribution of an apical membrane protein
from the TGN were unaffected. This analysis of TJ struc-
ture and function in the presence of different RhoA mu-
tants, coupled with the ability to examine the same cell pop-
ulation without mutant protein expression, provides new
insights into the roles of RhoA GTPases in controlling TJ
assembly, dynamics, and function.
 
Materials and Methods
 
Cell Culture
 
T23 MDCK cells expressing RhoAV14, RhoAN19, Rac1V12, or Rac1N17
under control of the tetracycline-repressible transactivator were described
in detail in the preceding study (Jou and Nelson, 1998). Parental T23 cells
and transfected cells were grown in DMEM containing 10% FBS and 20
ng/ml doxycycline (DC; Sigma Chemical Co., St Louis, MO) at 37
 
8
 
C in a
humidified atmosphere containing 5% CO
 
2
 
. Cultures were routinely mon-
itored for Mycoplasma infection. Generally, mutant genes were induced
to express for 16–18 h (RhoAV14, Rac1V12, Rac1N17) or 40 h
(RhoAN19) by removing DC (Sigma Chemical Co.) from the culture me-
dium before each experiment. In calcium-switch experiments, control and
mutant small GTPase-expressing cells were grown in the presence or ab-
sence of 20 ng/ml DC at low density, trypsinized, and plated onto 12-mm–
diameter Transwell™ filters (Corning Costar Corp., Cambridge, MA) in
medium containing 5 
 
m
 
M calcium (LCM) with or without 20ng/ml DC
(Nelson and Veshnock, 1987). Cells were incubated in LCM for 4 h, gently
rinsed in prewarmed LCM twice, and then incubated in DMEM/FBS con-
taining 1.8 mM calcium (HCM) with or without 20 ng/ml DC.
 
Adenovirus-mediated Expression of p75
 
NTR
 
cDNA encoding a receptor for nerve growth factor (p75
 
NTR
 
) was intro-
duced into polarized MDCK cells by adenovirus-mediated gene transfer
(Yeaman, et al., 1997). Replication-defective adenovirus vector encoding
p75
 
NTR
 
 (AdCMVp75) was kindly provided by Dr. Moses Chao (Cornell
University Medical College, New York). Recombinant adenovirus were
applied to the apical surface of MDCK cells grown on Transwell™ filters
in serum-free DMEM for 2 hr. After infection, DMEM/FBS was added
and cells were incubated at 37
 
8
 
C for 24 h.
 
Antibodies
 
The following antibodies were used: rabbit polyclonal anti-occludin anti-
body (Zymed Laboratories, Inc., South San Francisco, CA), rabbit poly-
clonal anti-myc antibody (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA), rabbit polyclonal anti-ZO-2 antibody (no. 9989) and rat anti-ZO-1
hybridoma R40.76 (Dr. D.A. Goodenough, Harvard Medical School,
Cambridge, MA), mouse anti-myc hybridoma 9E10 (Dr. Gordon Cann,
Stanford Univ. Med. Sch., Stanford, CA), mouse anti-p75 monoclonal an-
tibody (Dr. C. Yeaman, Stanford University, Stanford, CA), and affinity-
purified fluorescein and rhodamine-labeled secondary antibodies (Jack-
son ImmunoResearch Laboratories, Inc., West Grove, PA).
 
Transepithelial Electrical Resistance
(TER) Measurement 
 
TER was determined by applying an AC square wave current of 
 
6
 
 20 mA
at 12.5 Hz across a cell monolayer on a 12-mm–diameter Transwell™ fil-
ter, and measuring the voltage deflection with a pair of Ag/AgCl voltage
sensors (EVOM, World Precision Instruments). TER values were calcu-
lated by subtracting the blank values from the filter and the bathing me- 
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dium, and were normalized to the area of the monolayer (filter). Mono-
layer integrity was monitored after each TER time course study by
staining cells with Hoechst 33342 (Molecular Probes, Inc., Eugene, OR).
 
Measurement of Paracellular Diffusion of Nonionic 
Molecular Tracers
 
Paracellular flux assays were performed on confluent monolayers of
MDCK cells grown on rat tail collagen-coated polycarbonate Transwell™
filters (0.4-
 
m
 
m pore size, 12-mm diameter). Three different tracers were
used: [
 
3
 
H]inulin (Amersham Corp., Arlington Heights, IL), anionic dext-
ran (mol wt 3,000) conjugated with FITC (Molecular Probes, Inc.), and
neutral dextran (mol wt 40,000) conjugated with Texas Red (Molecular
Probes, Inc.). The assay was begun by replacing the apical compartment
medium with 200 
 
m
 
l DMEM containing one of the tracers (4 nM inulin,
0.2 mg/ml FITC-conjugated dextran [mol wt 3,000], or 0.5 mg/ml Texas
Red–conjugated dextran [mol wt 40,000]); basal compartment medium
was replaced with 600 
 
m
 
l DMEM/FBS without tracer. Cells were incu-
bated at 37
 
8
 
C for either 30 min (inulin) or 3 h (3K and 40K dextrans), and
then equal-volume aliquots of apical and basal compartment media were
collected, and the amount of [
 
3
 
H]inulin or 3K or 40K dextrans was deter-
mined in a scintillation counter or a fluorometer (Fluoroskan II™; K & M
Co., Torrance, CA), respectively. The amount of diffusible inulin or dextran
was calculated from a titration curve of known concentrations of the tracer.
 
Freeze-fracture EM
 
Monolayers of cells grown in 75-cm
 
2
 
 plastic tissue culture flasks (Becton
Dickinson, Franklin Lakes, NJ) or on 10 cm–diameter Transwell™ filters
were fixed in 0.1 M phosphate buffer, pH 7.4 containing 2% glutaralde-
hyde for 30 min at room temperature. After rinsing in phosphate buffer,
cells were removed from the substratum using a plastic cell scraper (Nunc
Inc., Naperville IL). The detached cells were infiltrated with 25% glycerol
in 0.1 M cacodylate buffer, pH 7.3, frozen in a liquid nitrogen slush, and
freeze-fractured in a Balzers 400 freeze fracture unit (Balzers, Liechten-
stein). Replicas were cleaned in sodium hypochlorite, washed in distilled
water, placed on Formvar-coated grids, and examined in a 301 electron
microscope (Philips, Eindhoven, Netherlands).
In a given replica, all grid squares were examined, and all TJ images
were photographed. The number of TJ parallel strands was measured on
electron micrographs by overlaying the area of the TJ with a transparency
marked at 1-cm intervals. Since the magnification on all micrographs ex-
amined was 62,500
 
3
 
, measurements were effectively made at 160-nm in-
tervals. Total TJ length examined by morphometry in each group ranged
from 49 to 79 
 
m
 
m. When histograms were constructed for the strand fre-
quency, the strand counts were normalized to the shortest total length
measured. Note that the strand distribution in the apical and lateral mem-
branes, and the frequently interrupted pattern of TJ strands in RhoAV14-
expressing cells complicated strand counting. Morphometric data were
analyzed as a parallel electrical circuit as described (Madara and Dharm-
sathaphorn, 1985). All freeze-fracture experiments were performed and
analyzed as a double-blind study.
 
Immunofluorescence Microscopy
 
Confluent monolayers of MDCK cells were grown on rat tail collagen-
coated coverslips or Transwell™ filters in DMEM/FBS with or without 20
ng/ml DC. Cells were washed twice with Dulbecco’s PBS (0.9 mM CaCl
 
2
 
,
2.7 mM KCl, 1.5 mM KH
 
2
 
PO
 
4
 
, 0.5 mM MgCl
 
2
 
, 137 mM NaCl, and 8.1 mM
Na
 
2
 
HPO
 
4
 
) and then fixed for 20 min at room temperature in 3.7%
paraformaldehyde in Dulbecco’s PBS. Cells were then washed twice in
Dulbecco’s PBS at room temperature for 10 min and extracted with CSK
buffer (50 mM NaCl, 300 mM sucrose, 10 mM Pipes, pH 6.8, 3 mM MgCl
 
2
 
,
0.5% [vol/vol] Triton X-100) at room temperature for 10 min. Cells were
washed twice in Dulbecco’s PBS at room temperature for 10 min. Cells
were blocked in Dulbecco’s PBS containing 1% BSA, 10% goat serum,
and 50 mM NH
 
4
 
Cl for 1 h at room temperature, or overnight at 4
 
8
 
C. After
blocking, cells were washed briefly in Dulbecco’s PBS and 0.2% BSA, and
then incubated in primary antibody solution for 1 h at room temperature
or overnight at 4
 
8
 
C. Cells were then washed three times in Dulbecco’s
PBS and 0.2% BSA, and incubated in fluorescein- or rhodamine-conju-
gated goat secondary antibody solution for 1 h at room temperature. Cells
were washed three times in Dulbecco’s PBS and 0.2% BSA, and were
mounted in either Elvanol (16.7% Mowiol, 33% glycerol, 0.1% phe-
nylenediamine), or Vectashield™ (Vector Laboratories, Inc., Burlingame,
CA). Cells were viewed with an Axioplan™ epifluorescence microscope
(Carl Zeiss, Inc., Thornwood, NY) using either a 40
 
3
 
 or 63
 
3
 
 oil immer-
sion objective. Alternatively, cells were viewed using a laser scanning con-
focal microscope MultiProbe 2010 (Molecular Dynamics, Sunnyvale, CA).
Fluorescent images of stained cells were recorded using Ektachrome Elite
II (ASA 400; Eastman Kodak Co., Rochester, NY) film. Photographic im-
ages were then digitized with a slide scanner (Nikon, Inc., Melville, NY)
and images were resized, arranged, and labeled using Adobe Photoshop
software (Adobe, Mountain View, CA). The resulting images were
printed from the computer file using a dye sublimation printer (Tektronix
Inc., Beaverton, OR). The images are representative of the original data.
 
Fluorescent Lipid Labeling of the Plasma Membrane
 
BODIPY-FL-C
 
5
 
 sphingomyelin (Molecular Probes. Inc.) and defatted
BSA (Boehringer Mannheim Corp., Indianapolis, IN) were used to pre-
pare sphingomyelin/BSA complexes (5 nmol/ml) in
 
 P 
 
buffer (10 mM
Hepes, pH 7.4, 1 mM sodium pyruvate, 10 mM glucose, 3 mM CaCl
 
2
 
, and
145 mM NaCl). Duplicate confluent monolayers of MDCK cells grown on
Transwell™ filters (12-mm diameter, 0.4-
 
m
 
m pore size) were used for flu-
orescent lipid labeling. Before labeling, cells were washed twice in pre-
chilled
 
 P 
 
buffer, and then 0.5 ml 5 
 
m
 
M sphingomyelin/BSA complex solu-
tion was added to the apical compartment while 1 ml
 
 P 
 
buffer was added
to the basal compartment. The incubation was performed for 10 min on
ice, and then both apical and basal compartment solutions were removed
and saved for further analysis. Filters were washed three times in cold
 
 P
 
buffer. One filter was immediately processed for confocal microscopy, and
the other filter was washed extensively in
 
 P 
 
buffer and then left on ice in
 
 P
 
buffer containing BSA for 1 h before confocal microscopy. 100 
 
m
 
l of solu-
tion was collected from the apical and basal medium after the initial incu-
bation, and was used to assess paracellular leakage of BSA/lipid complex
between filter compartments.
 
Immunoblotting
 
MDCK cells were grown on Transwell™ filters and extracted in 900 
 
m
 
l
Triton X-100 extraction buffer (0.5% [vol/vol] Triton X-100, 10 mM Tris-
HCl, pH 7.5, 120 mM NaCl, 25 mM KCl, and 1.8 mM CaCl
 
2
 
) containing
25 mg/ml pepstatin A, 1 mM Pefabloc, 1 mM benzamidine, 1% aprotinin,
100 mM leupeptin, 1 mM sodium vanadate, and 50 mM NaF on a rocker
platform for 10 min at 4
 
8
 
C. Cells were scraped from the filter using a rub-
ber policeman, and were centrifuged at 12,000 
 
g
 
 for 15 min at 4
 
8
 
C; pellets
were dissolved in 100 
 
m
 
l SDS-IP buffer (1% SDS, 10 mM Tris-HCl, pH
7.5, 2 mM EDTA) at 100
 
8
 
C, and were then diluted with 900 
 
m
 
l Triton X-100
extraction buffer; supernatants were adjusted with 100 
 
m
 
l SDS-IP buffer.
Protein concentrations in supernatants and pellets were determined using
the BCA protein assay reagent kit (Pierce Chemical Co., Rockford, IL).
Equal amounts of total protein (reconstituted by adding supernatant and
pellet fraction from each sample) or supernatant or pellet were separated
either in 5% (for ZO-1 and ZO-2) or 7.5% (for occludin) SDS-PAGE,
transferred electrophoretically to nitrocellulose filters, and processed for
immunoblotting with specific antibodies to occludin, ZO-1, or ZO-2. Im-
mune complexes were visualized with donkey anti–rabbit and sheep anti–
rat horseradish peroxidase–conjugated secondary antibodies (Amersham
Corp.) and developed using the ECL kit (Amersham Corp.). Chemilumi-
nescent signals were collected and scanned from autoradiography film
(Eastman Kodak Co.) into Adobe Photoshop software (Adobe, Mountain
View, CA) with a Scan-Jet IIc™ scanner (Hewlett-Packard Co., Greeley,
CO). The contrast of images was adjusted, arranged, and labeled for indi-
vidual figures in Adobe Photoshop. The resulting images were printed us-
ing a dye sublimation printer (Tektronix, Inc.). The printed images are
representative of the original data. Intensities of signals were measured
with National Institutes of Health Image 1.58 software.
 
Results
 
RhoA and Rac1 Mutants Disrupt TJ Gate Function: 
Transepithelial Resistance
 
The effects of mutant small GTPases on TJ function were
examined in MDCK cells after induction of cell–cell con-
tact. Different amounts of constitutively active or dominant
negative RhoA or Rac1 were expressed by varying the con- 
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centration of DC in the medium (20 ng/ml –0 pg/ml) as re-
ported in the previous study; these data are not shown again
here, but the reader is referred to the data in Figs. 1 and 3
in Jou and Nelson (1998).
TER of each mutant cell line was measured at different
times over a 24-h period after induction of cell–cell con-
tacts (see Materials and Methods). TER increased linearly
in control cells (T23 and pUHD10-3), reached 200–250
ohms per cm
 
2
 
 after 24 h, and was not affected by different
concentrations of DC (Fig. 1). In contrast, cells expressing
RhoA or Rac1 mutants showed a dose-dependent effect of
mutant protein on TER (RhoAV14, RhoAN19, Rac1V12,
and Rac1N17). In general, cells expressing RhoA or Rac1
mutants grown in the presence of 20 ng/ml DC developed
TER with kinetics similar to that of controls; at this DC
concentration, RhoA and Rac1 mutants were not ex-
pressed (Jou and Nelson, 1998). In the presence of 200 pg/
ml DC, cells expressing Rac1V12 and Rac1N17 developed
slightly lower than normal TER, but in cells expressing
RhoAV14 or RhoAN19, TER developed very poorly (Fig.
1); at this DC concentration, we detected very low levels
of RhoAV14, but levels of Rac1V12, Rac1N17, and
RhoAN19 were below that detectable by Western blotting
of whole cell extracts (Jou and Nelson, 1998). At concen-
trations of DC at or below 20 pg/ml, TER in all mutants
developed poorly to levels that were only 10–20% of that
of parental cells or mutant cells in which mutant gene ex-
pression was fully repressed. At 20 pg/ml DC, proteins
were expressed at 20% (Rac1V12), 50% (Rac1N17), 46%
(RhoAV14) and 13% (RhoAN19) of the respective en-
dogenous wild-type Rac1 or RhoA levels; in the absence
of DC, proteins were expressed at 104% (Rac1V12),
600% (Rac1N17), 200% (RhoAV14) or 60% (RhoAN19)
of the respective endogenous wild-type Rac1 or RhoA lev-
els (see Figs. 1 and 3 in Jou and Nelson, 1998). Note that
TER values obtained in cells fully expressing RhoA or
Rac1 mutants, while low compared with the levels for con-
trol cells, were still significantly higher than those reported
in some leaky epithelial cells. This result indicates that in
these mutants some TJ structure may be preserved, pro-
viding a minimal barrier function to paracellular ion flow.
Differences in TER sensitivity to the expression of RhoA
or Rac1 mutants were unlikely to be due to different kinet-
ics of gene induction. At 20 pg/ml DC, both RhoAV14 and
RhoAN19 expression were induced to 
 
z
 
50% of the level of
endogenous RhoA (Jou and Nelson, 1998), but RhoAV14
had a more profound effect on TER than did RhoAN19.
At 20 pg/ml DC, the level of Rac1V12 protein was similar
to that of endogenous Rac1 while Rac1N17 was induced
to level 
 
.
 
5
 
3
 
 that of endogenous Rac1 protein, and yet
Rac1V12 suppressed TER development more than Rac1N17.
These results indicate that RhoAV14 and Rac1V12 have
different regulatory effect(s) on TJ structure and function
than RhoAN19 or Rac1N17.
 
RhoA and Rac1 Mutants Disrupt TJ Gate Function: 
Nonionic Molecules
 
In addition to regulating paracellular ion flow (measured
by TER), the TJ also regulates diffusion of nonionic mole-
cules through the paracellular space. We examined the ef-
fects of RhoA or Rac1 mutants on the diffusion of three
nonionic tracers: [
 
3
 
H]inulin (mol wt 5,200), FITC-conju-
gated dextran (mol wt 3,000), and Texas Red–conjugated
dextran (mol wt 40,000; Fig. 2). Tracer diffusion was exam-
ined 18 h after induction of cell–cell contacts in confluent
monolayers of MDCK cells in which RhoA or Rac1 mu-
tant expression was either completely repressed (20 ng/ml
Figure 1. Development of TER in MDCK cells expressing con-
stitutively active or dominant negative RhoA or Rac1 mutants.
Control MDCK cells (T23), mock-transfected MDCK cells
(pUHD10-3), and cells expressing RhoAV14, RhoAN19,
Rac1V12, or Rac1N17 under control of the tetracycline repress-
ible transactivator were grown in different concentrations of DC
for 16 h at low cell density. Cells were trypsinized, plated on
Transwell™ filters as an instant confluent monolayer in LCM con-
taining different amounts of DC for 4 h, and then cell–cell con-
tacts were synchronously induced by switching to HCM contain-
ing different amounts of DC. TER (ohms per cm2) was measured
at different times after induction of cell–cell contacts (see Materi-
als and Methods). TER was measured in four filters for each cell
line and each DC concentration, and the data are reported as the
mean 6 SEM. At the end of the experiment, filters were fixed
and stained with Hoechst 33342 (Molecular Probes, Inc.) to check
the integrity of each monolayer. 
Jou et al. 
 
Effects on the Tight Junction
 
105
 
DC) or maximal (absence of DC). In control cells (T23,
pUHD), in the absence or presence of DC, minimal amounts
of [
 
3
 
H]inulin, 3K, and 40K dextran diffused through the
paracellular space (Fig. 2). All cell lines in which RhoA or
Rac1 mutant expression was repressed (
 
1
 
DC) also blocked
tracer diffusion to levels similar to those in controls (Fig. 2).
However, expression of RhoAV14, RhoAN19, Rac1V12,
or Rac1N17 caused a two- to sevenfold increase in paracel-
lular permeability to [
 
3
 
H]inulin, an 8- to 12-fold increase in
permeability to 3K dextran, and a 7- to 40-fold increase in
permeability to 40K dextran compared with controls (Fig.
2). Of the RhoA or Rac1 mutants examined, RhoAV14
was the most effective in disrupting TJ size selectivity to all
of the tracers tested, even though its expression level was
only slightly higher than those of RhoAN19 and Rac1V12,
and was considerably lower than that of Rac1N17 (see
above; Jou and Nelson, 1998). The other RhoA or Rac1
mutants were approximately equally effective in disrupt-
ing the diffusion barrier to the low–molecular weight
tracers [
 
3
 
H]inulin and 3K dextran (Fig. 2). However, there
was a progressive increase in potency of these mutants
(Rac1N17 
 
. 
 
Rac1V12 
 
. 
 
RhoAN19) to disrupt the barrier
to 40K dextran (Fig. 2). Taken together, we conclude that
the TJ gate function is disrupted in the presence of all mu-
tant GTPases.
 
RhoA and Rac1 Mutants Disrupt TJ
Strand Organization
 
Freeze-fracture EM of TJs in epithelial cells has revealed a
fine interconnected network of parallel strands and cross-
Figure 2. RhoA and Rac1 mutants disrupt TJ barrier to paracel-
lular diffusion of [3H]inulin, FITC-conjugated 3K dextran, and
Texas Red–conjugated 40K dextran. Control MDCK cells (T23),
mock-transfected MDCK cells (pUHD), and cells expressing
RhoAV14, RhoAN19, Rac1V12, or Rac1N17 under the control
of the tetracycline repressible transactivator, were cultured with
20 ng/ml DC or without DC at low cell density. Cells were
trypsinized and plated on Transwell™ filters at an instant conflu-
ent monolayer density in LCM (6 DC) for 4 h, and were then
switched to normal DMEM/FBS (6 DC). 16 h later, paracellular
tracer diffusion was measured in four parallel cultures for each
cell line 6 DC as described in Materials and Methods; the data
are shown as the mean 6 SEM.
Figure 3. Freeze-fracture EM of tight junction strand organiza-
tion in MDCK cells expressing RhoA mutants. (A and B) Repre-
sentative P fracture face of a TJ from MDCK cells expressing
RhoAV14 1DC (A) or 2DC (B). Fracture planes are oriented
with the apical membrane at the top (from left to right), and lat-
eral membranes are oriented downwards (bracket). Note the cha-
otically distributed TJ strands that extend basally from a disorga-
nized TJ (arrowheads) in RhoAV14 -DC cells (B). (C and D)
Representative P fracture face of a TJ from MDCK cells express-
ing RhoAN19 1DC (C) or 2DC (D). The strand organization of
the TJs in RhoAN19 1DC or 2DC are similar. Bars, 200 nm. 
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bridges (Staehelin, 1974). Although the molecular organi-
zation of proteins in these strands is poorly understood,
strand organization provides a measure of TJ integrity
(Claude, 1978). As expected from previous studies, freeze-
fracture analysis of the TJ region of control MDCK cells
(
 
1
 
DC) revealed a number of parallel strands and cross-
bridges that were restricted to the apex at the lateral mem-
branes (Fig. 3, 
 
A 
 
and
 
 C, 
 
and Fig. 4, 
 
A
 
 and 
 
C
 
; mutant 
 
1
 
DC); these images are similar to those described previ-
ously for MDCK cells (Stevenson et al., 1988).
Compared with the TJ strand organization in control
cells, freeze-fracture analysis of cells expressing RhoAV14
revealed a chaotic disorganized arrangement of strands at
the apical surface (Fig. 3 
 
B
 
); some regions of the mem-
brane were devoid of strands (which contributed to the
overall decrease in strand number [Fig. 5]), while others
contained multiple strands that interwove with each other
rather than forming parallel lines with cross-bridges (Fig. 3
 
B
 
). Significantly, we also found strands that extended from
the apical membrane down the lateral membrane to the
base of the cell (Fig. 3 
 
B). In contrast to the constitutively
active mutant, RhoAN19 expressing cells had a TJ ultra-
structure similar to that of control cells (Fig. 3 D). Strand
number and organization of parallel strands in cells ex-
pressing Rac1N17 also appeared similar to that in control
cells, although we detected a slight decrease in the number
of cross-bridges (Fig. 4 D). In cells expressing Rac1V12, we
found an increased frequency of TJ strands (Figs. 4, B and
B9, and Fig. 5). Significantly, as in the case of RhoAV14
cells, TJ strands in Rac1V12 cells were not only confined
to the apical membrane, but also extended down the lat-
eral membrane to the base of the cell (Fig. 4, B and B9).
In summary, freeze-fracture EM and functional analysis
revealed two important effects of RhoA or Rac1 mutants
on TJ organization. First, expression of either constitutively
active RhoA or Rac1 resulted in the general disorganiza-
tion of TJ strands at the apex of the lateral membrane and
extension of strands down the lateral membrane to the
base of cells. In contrast, expression of either dominant
negative RhoA or Rac1 had little effect on strand organi-
zation or distribution relative to controls. Second, despite
morphological differences in TJ strand organization in
cells expressing constitutively active or dominant negative
RhoA or Rac1, all RhoA and Rac1 mutants disrupted TJ
gate function to ions (TER) and nonionic molecules (in-
ulin, 3K, and 40K dextran).
Figure 4. Freeze-fracture EM of tight junction strand organiza-
tion in MDCK cells expressing Rac1 mutants. (A, B, and B9) Rep-
resentative P fracture face of a TJ from Rac1V12 1DC cells (A)
or E and P fracture face of Rac1V12-DC cells (B and B9, respec-
tively). Fracture planes are oriented with the apical membrane at
the top (from left to right) and lateral membranes oriented down-
wards (bracket). Note that strands extend from the tight junction
network down the lateral membrane to the base of the cells in
Rac1V12 -DC (B and B9). (C and D) Representative P fracture
face of a TJ from Rac1N17 1DC cells (C) and E fracture face of
a TJ from Rac1N17 2DC cells (D). There is a relative paucity of
cross-bridges in the TJ network, and a few TJ strands extend
basally on the lateral membrane surface in Rac1N17 2DC. Bars,
200 nm.
Figure 5. Quantitative analysis of TJ strand counts from freeze-
fracture replicas of cells expressing RhoAV14, RhoAN19,
Rac1V12, or Rac1N17 (2DC) and their matched controls
(1DC); see Materials and Methods for details.Jou et al. Effects on the Tight Junction 107
croscopy of control cells (e.g., RhoAV141DC) revealed
sharp circumferential organizations of both occludin and
ZO-1 at the apex of the lateral membrane between adja-
cent cells (Fig. 6); the distribution of these proteins was
identical to those in parental T23 cells (data not shown). In
RhoAV14 cells, occludin was chaotically distributed with
discontinuous membrane and cytosolic staining. In some
RhoAV14 cells, ZO-1 staining appeared to be separated
into several overlapping lines instead of the sharp line that
circumscribed the apex of control cells (Fig. 6). In contrast,
occludin and ZO-1 in RhoAN19 cells exhibited normal
organizations that were similar to those in control cells
(Fig. 6).
In Rac1V12-expressing cells, occludin staining circum-
scribed the apical membrane at the apex of the lateral
membranes, although lines of staining were often discon-
tinuous at the vertices of contacts between three or more
cells (Fig. 6). Occludin staining was also thicker en face
than in control cells (Fig. 6), and appeared more like the
lateral membrane staining of E-cadherin (data not shown).
ZO-1 staining in Rac1V12 cells was not as sharp, but was
more thick than in control cells, and the lines of ZO-1 ap-
peared beaded rather than continuous (Fig. 6). In contrast,
the staining patterns of occludin and ZO-1 in Rac1N17
cells appeared similar to those in control cells (Fig. 6).
TJ protein distributions were examined further by laser
scanning confocal microscopy (Fig. 7). In control cells
(e.g., RhoAV141DC), both occludin and ZO-1 were re-
stricted to the top of the lateral membrane at the junction
with the apical membrane, and little or no staining was de-
tected on apical, lateral, or basal membranes (Fig. 7).
However, in RhoAV14- or Rac1V12-expressing cells, both
occludin and ZO-1 distributions were disorganized; stain-
ing was not confined to the apex of lateral membrane, but
was present along the whole length of the lateral mem-
brane (Fig. 7). Furthermore, linear arrays of occludin and
ZO-1 staining were frequently interrupted and, in some
areas, separated into several parallel or interwoven strands
(Fig. 7). In general, occludin and ZO-1 staining appeared
more disorganized in cells expressing RhoAV14. Occludin
and ZO-1 distributions in RhoAN19- or Rac1N17-express-
ing cells appeared normal and similar to those in control
cells (Fig. 7).
We conclude that normal patterns of occludin and ZO-1
staining in control cells and Rac1N17- and RhoAN19-
expressing cells correlated well with normal TJ strand or-
ganization observed by freeze-fracture EM. Abnormalities
in occludin and ZO-1 organization (discontinuities, sepa-
rated lines, and lateral membrane distribution) in cells ex-
pressing RhoAV14 and Rac1V12 correlated with disorga-
nized, interwoven and lateral membrane strands observed
by freeze-fracture analysis.
Reversibility of TJ Structural and Functional Defects 
Induced by RhoA and Rac1 Mutants
A DC switch protocol was used to test whether the effects
of RhoA and Rac1 mutants on TJ structure and function
were reversible (Fig. 8). Two cultures were initiated for
each cell line; one culture formed cell–cell contacts in the
presence of DC (i.e., in the absence of mutant protein ex-
pression), and the other formed cell–cell contacts in the
Figure 6. Indirect immunofluorescence microscopy of occludin
and ZO-1 in MDCK cells expressing RhoA and Rac1 mutants.
MDCK cells expressing RhoAV14, RhoAN19, Rac1V12, or
Rac1N17 were grown in the presence (control, 1 20 ng/ml DC)
or absence of DC (2DC) for 36 h at a confluent cell density on
collagen-coated glass coverslips. Cells were processed for immu-
nofluorescence with either occludin or ZO-1 antibodies, as de-
scribed in detail in Materials and Methods. Stained cells were
viewed with a Axioplan microscope (Carl Zeiss, Inc.) equipped
for epifluorescence. Bar, 10 mm.
Disruption of Occludin and ZO-1 Distributions by
Constitutively Active, but not by Dominant Negative
RhoA and Rac1 Mutants
We examined whether changes in TJ gate function and
strand organization induced by RhoA and Rac1 mutants
correlated with changes in the organization of occludin, a
TJ transmembrane protein (Furuse et al., 1993), and ZO-1,
a TJ plaque protein (Itoh et al., 1993; Willott et al. 1993;
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cm2. In contrast, cells expressing RhoA or Rac1 mutants
(2DC) generally had considerably lower TER values than
did control cells (Fig. 8), as expected (see also Fig. 1).
DC was removed from the 1DC control cells (1DC ®
2DC group) to allow Rac1 or RhoA mutant expression,
and was added to cells to repress RhoA or Rac1 mutant
expression (2DC ® 1 DC group); the time of the DC
switch is marked by an arrowhead in Fig. 8. In addition,
2.5 mM Na-butyrate was added to the culture medium be-
tween 56 and 92 h to induce RhoA or Rac1 mutant expres-
sion further in the 1DC ® 2DC group; Na-butyrate de-
creased TER in control cells by ,20%, but had no effect
on recovery of TER in the 2DC ® 1DC group (Fig. 8).
After a delay, the TER of the 1DC ® 2DC group began
to decrease; the final TER level obtained at 120 h was sim-
ilar to the TER at the beginning of TJ assembly when
RhoA or Rac1 mutants were not expressed, but was gen-
erally higher than the TER of the same cells when RhoA
or Rac1 mutants were expressed throughout the period of
TJ formation. Those cell lines that had formed a leaky
monolayer (TER, z15–120 ohms per cm2) during the pe-
riod when RhoA or Rac1 mutants were expressed (2DC),
were converted to a tighter monolayer (TER, .300 ohms
per cm2) upon repression of RhoA or Rac1 mutant expres-
sion (1DC); the kinetics of TER development were simi-
lar in this group to those in control cells during TJ forma-
tion in the absence of RhoA or Rac1 mutant expression
(Fig. 8). In general, the final TER level obtained after
120 h was similar to the maximum levels obtained when
TER developed in the absence of RhoA or Rac1 mutant
expression.
For comparison with TJ function, the distributions of oc-
cludin and ZO-1 were examined by immunofluorescence
microscopy at the end of the DC switch protocol; myc anti-
body staining was used to monitor the expression or re-
pression of RhoA or Rac1 mutants in the 1DC ® 2DC
and 2DC ® 1DC groups, respectively (Fig. 9). Little or
no myc staining was detected in all the 2DC ® 1DC
group cells, demonstrating that RhoA or Rac1 mutant ex-
pression had been repressed. In the 2DC ® 1DC group
of cells, occludin and ZO-1 staining sharply circumscribed
each cell at the apex of lateral membranes (Fig. 9), similar
to staining patterns of these proteins in control cells (see
Figure 8. DC switch experiment to examine the reversibility of
defects in TJ function caused by RhoA and Rac1 mutants.
MDCK cells expressing RhoAV14, RhoAN19, Rac1V12, or
Rac1N17 were divided into two populations. One population of
each cell line (1DC ®2DC group) was grown initially in
DMEM/FBS  1 20 ng/ml DC, and then switched to medium with-
out DC at the indicated time (arrowhead). The other population
(2DC ® 1DC group) was grown at first without DC and then
switched to medium containing 20 ng/ml DC (arrowhead). 2.5 mM
sodium butyrate was added between 56 and 96 h to enhance
RhoA and Rac1 mutant expression. TER was measured in qua-
druplicate cultures, and is reported as mean 6 SEM.
Figure 7. Confocal microscopy analysis of occludin and ZO-1 distribution in MDCK cells expressing RhoA and Rac1 mutants. MDCK
cells expressing RhoAV14, RhoAN19, Rac1V12, or Rac1N17 were grown in the presence (control, 1 20ng/ml DC) or absence of DC
(2DC) for 36 h at a confluent cell density on collagen I–coated glass coverslips. Cells were fixed, permeabilized, and double-stained
with rabbit antioccludin antibody and rat anti-ZO-1 R40.76 hybridoma supernatant, followed by rhodamine-conjugated goat anti–rabbit
and FITC-conjugated goat anti–rat secondary antibodies. The images were collected with a laser scanning confocal microscope Multi-
Probe 2010™ (Molecular Dynamics, Inc.). Bar, 10 mm.
absence of DC (i.e., mutant proteins were expressed). Af-
ter 32 h, TJs in control cells (T23, pUHD 6 DC) or cells in
which mutant RhoA or Rac1 expression had been re-
pressed (1DC) had established TER of 200–300 ohms perJou et al. Effects on the Tight Junction 109
Fig. 6). The normal distributions of occludin and ZO-1
correlated with the recovery of high TER values in those
cells (see Fig. 8).
In the 1DC ® 2DC group, myc staining showed that
RhoAV14 and Rac1V12 were expressed and distributed in
the cytoplasm and cell–cell contacts, respectively, as ex-
pected (see Fig. 3 in Jou and Nelson, 1998). RhoAV14 and
Rac1V12 expression correlated with abnormal occludin
and ZO-1 distributions (Fig. 9), as expected (see Figs. 6
and 7). RhoAN19 and Rac1N17 were localized to the cyto-
plasm and cell–cell contacts, respectively (Fig. 9), as ex-
pected (Fig. 3 in Jou and Nelson, 1998). Occludin and
ZO-1 staining in RhoAN19 and Rac1N17 cells appeared
normal, and was similar to that in control cells (Figs. 6
and 7) even though these cells had functionally leaky TJ
(Fig. 8).
The reversibility of the effects of RhoA and Rac1 mu-
tants on both TJ function and protein distributions shows
that Rac1 and RhoA regulate TJ function transiently, and
not in a toxic fashion. Furthermore, both TJ structure and
function are dynamic and subject to RhoA and Rac1 regu-
lation, even after the junctional complex has been fully as-
sembled and tightly sealed.
TJ Fence Function is Perturbed by RhoA and
Rac1 Mutants
In addition to forming a gate to paracellular flow, the TJ
also forms a fence for free diffusion of lipids in the outer
leaflet of the plasma membrane between the apical and
basal-lateral membrane domains. We compared TJ fence
function in control cells and cells expressing RhoA or
Rac1 mutants by analyzing lipid diffusion (Fig. 10). Apical
membranes were labeled with BODIPY-sphingomyelin
for 10 min on ice. The cells were then washed extensively
and either immediately processed for confocal microscopy
Figure 9. Indirect immuno-
fluorescence of myc-tagged
RhoA or Rac1 mutants, oc-
cludin, and ZO-1 distribu-
tions at the end of the DC
switch experiment shown in
Fig. 8. MDCK cells express-
ing RhoAV14, RhoAN19,
Rac1V12, or Rac1N17 were
divided into two populations.
One population of each cell
line was grown initially in
DMEM/FBS  1 20 ng/ml DC,
and then switched to medium
without DC 32 h later (1DC
®  2DC group). The other
population (2DC ® 1DC
group) was grown at first
without DC and then
switched to medium contain-
ing 20 ng/ml DC. 2.5 mM so-
dium butyrate was added be-
tween 56 and 96 h to enhance
RhoA and Rac1 mutant ex-
pression. Immunofluores-
cence was performed at the end of the DC switch experiment by staining the filters with mouse anti-myc antibody (to identify the myc-
tagged RhoA or Rac1 mutant), rabbit anti-occludin antibody, and rat anti-ZO-1 (R40.76 hybridoma) antibody. Cells were examined in
a Axioplan™ microscope (Carl Zeiss, Inc.) equipped with epifluorescence. Bar, 10 mm.
Figure 10. Diffusion of fluo-
rescent lipid from the apical
to lateral membranes in cells
expressing RhoA and Rac1
mutants. MDCK cells expres-
sing RhoAV14, RhoAN19,
Rac1V12, or Rac1N17 were
cultured on Transwell™ fil-
ters in the presence (1DC)
or absence (2DC) of DC.
The apical surface was incu-
bated in BODIPY-sphingo-
myelin/BSA complex solu-
tion on ice for 10 min (see
Materials and Methods). The cells were washed three times in P buffer, and were then either immediately processed for microscopy (0
min) or incubated for an additional 60 min (60 min) on ice before processing. The distribution of fluorescent lipid was determined with
a Molecular Dynamics confocal microscope, and representative xz projections are shown. Bar, 10 mm.The Journal of Cell Biology, Volume 142, 1998 110
(0 min) or incubated in buffer for a further 60 min on ice.
As shown in Fig. 10, membrane-labeled BODIPY–sphin-
gomyelin was restricted to the apical membrane of con-
trols cells (1DC) after either the 10-min pulse (0 min) or
the 60-min chase; note that the apical membrane is domed
in the xz profile, which can give the erroneous appearance
of lateral membrane staining.
In cells expressing RhoAN19, Rac1V12, or Rac1N17,
BODIPY-sphingomyelin labeled the apical membrane af-
ter the 10-min pulse (0 min), but not the lateral mem-
brane; some lateral membrane labeling was detected in
cells expressing RhoAV14, although the apical membrane
was also very domed in these cells (Fig. 10). After a 60-min
chase, BODIPY-sphingomyelin was detected in both the
apical and lateral membranes of all cells expressing RhoA
or Rac1 mutants (Fig. 10).
The gate function of TJs in RhoA- and Rac1-expressing
cells is disrupted (Figs. 1 and 2). Therefore, it is possible
that lateral membrane labeling with BODIPY-sphingomy-
elin in these cells was the result of lipid diffusing in solu-
tion across the TJ. To test for this possibility, an aliquot of
solution was recovered from the apical and the basal com-
partment of each filter after the 10-min pulse. Spectro-
scopic measurement of BODIPY-sphingomyelin levels
showed that ,0.1% of the fluorescence present in the api-
cal compartment had leaked into the basal compartment
during the labeling period (data not shown), indicating
that lateral membrane labeling with BODIPY-sphingomy-
elin was most likely due to diffusion of lipid in the plane of
the lipid bilayer. In addition, we included BSA in the
chase P buffer in order to exclude the possibility that the
presence of BODIPY-sphingomyelin in the lateral mem-
branes of these cells was due to exchange of apical mem-
brane BODIPY-sphingomyelin into the buffer, and then
reinsertion into the lateral membrane. Although the fluo-
rescence signal was diminished in all membranes due to di-
rect extraction of some lipid by BSA, we still detected BO-
DIPY-sphingomyelin in the lateral membranes of cells
expressing mutant RhoA or Rac1 (data not shown).
Effects of Mutant RhoA and Rac1 on Protein Delivery 
to the Apical Membrane
As the TJ fence-to-lipid diffusion is disrupted in cells ex-
pressing RhoA or Rac1 mutants, we considered whether
the organization of membrane proteins at apical and
basal-lateral membrane domains was also disrupted. We
examined delivery to the cell surface and membrane do-
main organization of p75NTR (Fig. 11), a membrane protein
that is targeted and restricted to the apical membrane of
MDCK cells (Le Bivic et al., 1991; Yeaman et al., 1997).
MDCK cells were grown at low density for 24 h without
DC to induce expression of RhoA or Rac1 mutants. Cells
were trypsinized and plated at confluent density in LCM,
and then switched to HCM to induce cell–cell adhesion for
24 h. Cells were infected with recombinant adenovirus en-
coding p75NTR, and then processed for immunofluores-
cence after a further 24 h. Results show clearly that p75NTR
was localized to the apical membrane of cells expressing
either RhoAV14, RhoAN19, Rac1V12, or Rac1N17; little
or no staining was detected on lateral or basal membranes
(Fig. 11). These results indicate that delivery of p75NTR
from the TGN to the apical membrane was not disrupted
in the presence of RhoA or Rac1 mutants, and that p75NTR
did not diffuse from the apical membrane across the TJ
into the lateral membrane.
Expression of Mutant RhoA or Rac1 Does Not Change 
the Expression of the Occludin/ZO-1/ZO-2 Complex, 
but Affects the Detergent Solubility of ZO-1
Effects of mutant RhoA and Rac1 expression on steady-
Figure 11. Distribution of
the apical membrane pro-
tein, p75NTR, in MDCK
cells  expressing RhoA and
Rac1 mutants. MDCK
cells  expressing RhoAV14,
RhoAN19, Rac1V12, or
Rac1N17 were grown in the
presence (1DC) or absence
(2DC) of 20 ng/ml DC at
low cell density for 20 h, trypsinized, and plated at confluent cell density on Transwell™ filters. Cells were incubated for a further 48 h in
the presence or absence of 20 ng/ml DC. p75NTR-expressing adenovirus was applied to the monolayer. 24 h after adenovirus infection,
filters were fixed, permeabilized, and double-stained with mouse anti-p75 and rabbit anti-myc antibody followed by FITC-conjugated
goat anti–mouse and rhodamine-conjugated goat anti–rabbit secondary antibodies. Cells were examined with a Molecular Dynamics
confocal microscope, and representative stacked xy and xz projections of p75NTR staining are shown. Bar, 10 mm.
Figure 12. Western blot analysis of occludin, ZO-1, and ZO-2
levels in MDCK cells expressing RhoA and Rac1 mutants. 30 mg
of total protein lysates from MDCK cells expressing RhoAV14,
RhoAN19, Rac1V12, or Rac1N17 grown in the presence (1DC)
or absence (2DC) of 20 ng/ml DC was separated by SDS-PAGE,
proteins were transferred electrophoretically to nitrocellulose fil-
ters and probed with antibodies specific for ZO-1, ZO-2, and oc-
cludin. For details, see Materials and Methods.Jou et al. Effects on the Tight Junction 111
state protein levels of occludin, ZO-, and ZO-2 were ex-
amined in Western blots of whole-cell lysates. In general,
steady-state levels of occludin, ZO-1, and ZO-2 were simi-
lar in cells expressing RhoAN19, Rac1V12, or Rac1N17,
and control cells (1DC; Fig. 12). Expression of RhoAV14
coincided with a small decrease (25% decrease compared
with the protein level in control cells) in the level of occlu-
din, but there was little or no change in levels of either
ZO-1 or ZO-2.
We sought to examine whether mutant RhoA or Rac1
affected the occludin/ZO-1 complex. We attempted to
coimmunoprecipitate the complex with occludin antibod-
ies and blot back with ZO-1 antibodies. We detected ZO-1
in occludin-specific immunoprecipitates from both control
cells and cells expressing RhoA or Rac1 mutants, but the
ZO-1 signal was too low in both cases to draw any strong
conclusion (data not shown). We also used Superose 6
FPLC to fractionate proteins from detergent extracts of
cells expressing RhoA or Rac1 mutants. Results showed
little or no association of these proteins under these ex-
traction and separation conditions; we did not detect any
change in the elution profiles of occludin, ZO-1, or ZO-2
compared with the appropriate controls (data not shown).
Finally, we examined whether there were any differ-
ences in the extractability of the occludin/ZO-1/ZO-2
complex from cells in buffer containing Triton X-100 (Fig.
13). In control cells, most of the ZO-1, ZO-2, and occludin
were extracted from cells. However, in cells expressing
RhoAV14, we detected an increase in the Triton X-100
solubility of ZO-1. In contrast, expression of dominant
negative RhoA coincided with a decrease in ZO-1 extract-
ability. We did not detect any change in the Triton X-100
extractability of occludin or ZO-2 in cells expressing either
constitutively active or dominant negative RhoA or Rac1
mutants.
Discussion
Previous studies of RhoA family members have mostly fo-
cused on the effects of mutant RhoA or Rac1 on actin, and
the consequential changes in actin structures at the plasma
membrane of single, motile cells (Hall, 1998). The role(s)
of RhoA and Rac1 in regulating other cellular structures,
particularly in the context of the organization of epithelial
cells in tissues, is less well understood. Here, we focused
on the effects of mutant RhoA or Rac1 expression on TJ
gate and fence functions. Our results indicate that RhoA
and Rac1 regulate both the gate and fence functions of the
TJ, and effect restriction of TJ proteins to the boundary of
the apical/lateral membranes.
TJ Gate and Fence Functions are Disrupted by RhoA 
and Rac1 Mutants
TJ gate function was assessed by measuring the TER and
nonionic molecules (inulin, 3K, and 40K dextran) through
the paracellular pathway. We found that gate function was
very sensitive to disruption by levels of expression of ei-
ther constitutively active or dominant negative RhoA or
Rac1 that were 10–40% of the levels of endogenous RhoA
or Rac1. That substoichiometric levels of RhoA or Rac1 mu-
tants disrupted TJ function indicates that mutant GTPases
displace rapidly cycling endogenous GTPases from targets
and, because catalytic cycling is inhibited by the mutation,
mutant proteins remain bound to the target and accumu-
late, thereby resulting in quick domination of the mutant
phenotype (see also Jou and Nelson, 1998).
In addition to disrupting gate function, we showed that
RhoA and Rac1 mutants disrupted TJ fence function as
indicated by the diffusion of BODIPY-sphingomyelin
from the apical to the lateral membrane. That sphingomy-
elin was apparently free to diffuse across the TJ was sur-
prising in light of the results of the preceding study in
which E-cadherin was correctly localized to the basal-lat-
eral membrane in the same cells (Jou and Nelson, 1998).
However, the distribution of E-cadherin may not be a
good test of TJ fence function as E-cadherin binds to the
actin cytoskeleton (Nagafuchi and Takeichi, 1988), which
restricts its mobility in the plane of the lipid bilayer (C.
Adams, Y.-T. Chen, S. J. Smith, and W.J. Nelson, manu-
script submitted for publication). The apical membrane
protein p75NTR is a better test since it does not bind to the
actin cytoskeleton (Le Bivic et al., 1991; Yeaman et al.,
1997). Using an adenovirus-mediated expression system to
pulse-express p75NTR, we found that p75NTR accumulated
Figure 13. Triton X-100 solu-
bility of occludin, ZO-1, and
ZO-2 in MDCK cells ex-
pressing RhoA or Rac1 mu-
tants. MDCK cells express-
ing RhoAV14, RhoAN19,
Rac1V12, or Rac1N17 were
grown in the presence
(1DC) or absence (-DC) of
20 ng/ml DC on Transwell™
filters. Cells were extracted
in buffer containing 1% Tri-
ton X-100 on ice for 20 min,
and equal portions of the pel-
let (P) and supernatant (S)
were separated by high-
speed centrifugation. Proteins in equal amounts of pellet and supernatant samples were separated by SDS-PAGE, transferred electro-
phoretically to nitrocellulose filters, and probed with antibodies specific for ZO-1, ZO-2, and occludin. For details, see Materials and
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in the apical membrane of control cells and cells express-
ing RhoA or Rac1 mutants. These results show that the TJ
fence-to-protein diffusion was not disrupted, and indicate
that TJ protein/strand organization is sufficiently dis-
rupted to allow lipids, but not proteins, to diffuse through
the TJ fence.
Significantly, we found that disruptions of TJ gate and
fence functions by RhoA and Rac1 mutants did not corre-
late with a direct role of RhoA or Rac1 in regulating TJ
protein organization. Although RhoAV14 and Rac1V12
disrupted TJ function and protein and strand organization,
neither RhoAN19 nor Rac1N17 caused gross changes in
occludin or ZO-1 distributions or TJ strand organization.
Dominant negative mutant GTPases are thought to affect
endogenous GTPase functions by sequestering regulators
of the GTPase cycle (e.g., GEF), thereby inhibiting the ac-
tivity of the endogenous GTPase (Boguski and McCor-
mick, 1993); in this capacity, the expression level of a dom-
inant negative mutant is likely to be critical. We note that
effects on TER were detected at levels of expression of
RhoAN19 and Rac1N17 that were 13 and 50% of endoge-
nous RhoA and Rac1 levels, respectively (Jou and Nelson,
1998), indicating that changes in TJ organization were
acutely sensitive to levels of dominant negative RhoA and
Rac1. In addition, while full expression of RhoAN19 was
only 60% of the endogenous RhoA level, Rac1N17 was
expressed at .600% of the level of endogenous Rac1 (Jou
and Nelson, 1998). Together, these results indicate that ex-
pression levels of RhoAN19 and Rac1N17 were suffi-
ciently high to affect TJ function, but not TJ protein orga-
nization.
The effects of RhoA mutants on TJ structure and func-
tion that we observed are different from those reported in
previous studies. Nusrat et al. (1995) used a recombinant
bacterial toxin to deliver C3, an inhibitor of endogenous
RhoA function, into T84 cells. They observed a defective
TJ gate function and loss of ZO-1 staining from the TJ re-
gion. Our results show that dominant negative RhoA
(RhoAN19) expression induced a leaky TJ gate junction
in MDCK cells without any apparent effects on either TJ
protein (occludin, ZO-1) localization or TJ strand organi-
zation. The discrepancy between these results could be
due to the different expression systems adopted, or the
level of expression of either C3 toxin or mutant protein
(but see above). We note, however, that a morphologically
normal but functionally defective TJ has been described in
animal models of colitis in which intestinal and biliary epi-
thelia became leaky without any accompanying morpho-
logical changes to the TJ (Cui et al., 1996; Lora et al.,
1997).
During final stages of the present work, Takaishi et al.
(1997) reported the effects of constitutively expressed
RhoA and Rac1 mutants on MDCK cells. They observed
no effect of RhoAV14, Rac1V12, or Rac1N17 expression
on ZO-1 distribution compared with an untransfected con-
trol cell population. Effects of RhoAN19 on cells were not
presented. However, microinjection of C3 exoenzyme dis-
rupted the distribution of ZO-1 in some cells, but not in
others. In comparison to our results, it is unclear why Ta-
kaishi et al. (1997) did not detect morphological changes
to the TJ in MDCK cells expressing either RhoAV14 or
Rac1V12. A possible explanation is that different amounts
of RhoA and Rac1 mutants were expressed. Takaishi et al.
(1997) reported that the amount of RhoAV14 was ,10%
of that of endogenous RhoA, and Rac1V12 and Rac1N17
expression could not be detected in Western blots of
whole cell extracts.
Roles of RhoA and Rac1 in Regulating TJ Assembly, 
Structure, and Function
Based on our direct comparison of TJ function with TJ
structure, we can identify at least two levels of TJ regula-
tion by RhoA and Rac1. One level involves an indirect ef-
fect on mechanisms involved in restricting TJ proteins and
strands to the boundary of the apical/lateral membrane.
The second level involves direct regulation of TJ gate, and
at least some fence functions. Regulation of TJ structure
and function by RhoA and Rac1 is likely to be very dy-
namic. The DC switch experiment (Figs. 8 and 9) showed
that effects of these mutants on TJ structure and function
were completely reversible, and that expression of each
mutant could disrupt TJs that had formed normally. That
both active and dominant negative forms of RhoA or
Rac1 have similar effects on TJ structure and function is
not unexpected, as both mutant forms of GTPases have
been shown to have similar rather than opposite effects in
other cell culture systems (Stowers et al., 1995; Anand et
al., 1997) or whole organisms (Luo et al., 1994).
Role of RhoA and Rac1 in TJ Assembly
Although all cells expressing RhoA and Rac1 mutants ex-
hibited disrupted gate and fence functions, only cells ex-
pressing constitutively active RhoA (RhoAV14) and Rac1
(Rac1V12) had clearly disrupted TJ structures. TJ strands
and occludin/ZO-1 staining circumscribed the apical mem-
brane, but the organization was chaotic as parallel strands/
rings of protein separated over a short distance and then
interwove with each other. Most striking, however, was
the finding that TJ strands and occludin/ZO-1 staining ex-
tended down the whole length of the lateral membrane to
the base of cells expressing RhoAV14 or Rac1V12. The
structural basis for this gross disruption of TJ structure is
not known. We did not detect major changes in the steady
state amounts of occludin, ZO-1, or ZO-2, except a 25%
decrease in occludin levels in RhoAV14-expressing cells.
We attempted several approaches to identify an occludin/
ZO-1 complex, but even in control cells the complex was
easily disrupted during protein extraction. However, we
detected a small but reproducible increase in the Triton
X-100 extractability of ZO-1 in RhoAV14 mutant–express-
ing cells, but not occludin or ZO-2, that might reflect a
change in the binding of ZO-1 to actin filaments or a
change in actin organization. We note that these gross de-
fects in TJ strand organization and protein distributions in
the presence of Rac1V12 and RhoAV14 were completely
and rapidly reversed upon repression of mutant gene ex-
pression (DC switch experiment, see Fig. 8), indicating
that they were neither toxic nor a dead end in the assem-
bly of a functional TJ.
Previous studies have shown that TJ assembly is depen-
dent on cadherin-mediated cell–cell adhesion (Gumbiner
et al., 1988). Furthermore, the distributions of occludin/Jou et al. Effects on the Tight Junction 113
ZO-1 and cadherin are initially similar upon cell–cell ad-
hesion, but subsequently occludin/ZO-1 dissociates from
the cadherin organization and redistributes to the apex of
the lateral membrane together with the cortical actin belt
(see van Itallie and Anderson, 1997). We suggest that the
abnormal organization of occludin/ZO-1 at the lateral
membrane of polarized cells expressing Rac1V12 or
RhoAV14 is due to an inhibition of this latter step in TJ
assembly. Although the mechanisms involved are not
known, we speculate that changes to the normal organiza-
tion of the actin cytoskeleton at cell–cell contacts may in-
hibit dynamic alterations in occludin/ZO-1 distribution
necessary for TJ assembly. We found that expression of
RhoAV14 and Rac1V12 caused dramatic changes in actin
organization, including clumping at the apical membrane
(Rac1V12), formation of thick bundles at the lateral mem-
brane (Rac1V12), and increased numbers of stress fibers
at the base of the cell (RhoAV14; Jou and Nelson, 1998).
These changes in actin organization could decrease dy-
namic changes in protein–protein interactions that may
be necessary to separate occludin/ZO-1 complexes from
E-cadherin/catenin complexes to assemble the TJ at the
apex of the lateral membrane.
In the context of the lateral membrane distribution of
occludin in Rac1V12 and RhoAV14 cells, it is striking that
a similar lateral membrane distribution has been described
in proximal convoluted renal tubules of human (Kwan, O.,
G.D. Myers, R. Sibley, D. Dafoe, E. Alfrey, and W.J. Nel-
son, manuscript submitted for publication) and mouse (P.
Piepenhagen and W.J.Nelson, unpublished results); in dis-
tal convoluted tubules, occludin staining is restricted to the
apex of the lateral membrane (O. Kwan, G.D. Myers, R.
Sibley, D. Datoe, E. Alfrey, and W.J. Nelson, manuscript
submitted for publication). Significantly, proximal renal
tubule epithelia are classified as leaky, whereas distal tu-
bule epithelia are classified as tight. We do not know if oc-
cludin distribution is regulated by RhoA family members
in renal tubule epithelia, but Rho-related small GTP-bind-
ing proteins are enriched in regions of kidney cortex that
contain proximal convoluted tubules (Boivin and Beli-
veau, 1995).
Roles of RhoA and Rac1 in TJ Structure and Function
The structural basis for TJ gate and fence functions is
poorly understood. Previous studies sought to establish a
relationship between TJ strand number and function
(Claude, 1978), but it has been difficult to extrapolate gen-
eralizations to all cell types (Stevenson et al., 1988). Our
studies showed that TJ strand organization in RhoAN19
and Rac1N17 cells appeared normal, but TJ fence and gate
functions were disrupted. In the case of the TJ fence we
found that the barrier to lipid, but not protein diffusion,
was disrupted. It is possible that maintenance of TJ fence
function to protein diffusion in these mutants might not be
due to the TJ fence per se, but to a general decrease in
protein mobility as a result of global changes in the actin
cytoskeleton and actin-associated membrane proteins (see
Jou and Nelson, 1998). Alternatively, there might be suffi-
cient structural organization in the TJ to prevent protein,
but not lipid diffusion, into the lateral membrane in cells
expressing RhoA/Rac1 mutants. In this latter case, the TJ
fence would behave as a molecular sieve that determines
molecule diffusion based on size; size selectivity could be
modulated by adjusting the number of parallel strands, the
spacing between parallel strands, and the frequency of
cross-bridges. A similar mechanism could regulate TJ gate
function, in which interdigitating TJ strands on the extra-
cellular surface of opposing membranes form a molecular
sieve to regulate ion and solute diffusion along the para-
cellular pathway.
At present it is not clear how TJ protein organization
might alter TJ barrier functions. Although recent studies
have cast doubt on the central role of occludin in TJ func-
tions (Saitou et al., 1998), earlier studies indicated that
changes in the amount of occludin expressed and its pro-
tein interactions might be functionally important. For ex-
ample, overexpression of COOH-terminal truncated oc-
cludin caused a two to threefold increase in TER and an
increase in tracer diffusion through the paracellular space,
but normal TJ strand organization (Balda et al., 1996).
Overexpression of full- length occludin in MDCK cells
also resulted in an z35% increase in TER and an increase
in tracer diffusion across the monolayer, but an increase in
TJ strand number and network width (McCarthy et al.,
1996). At present, it is not clear whether changes in RhoA/
Rac1 functions and altered TJ structure by overexpressing
occludin disrupt TJ function through the same or different
pathways.
How might RhoA or Rac1 regulate the organization of
TJ strands/protein complexes to specify gate and fence
functions? We did not find gross abnormalities in TJ
strand/protein organization in the presence of dominant
negative RhoA or Rac1, indicating that neither RhoA nor
Rac1 activity is necessary at this level of organization. Al-
ternatively, RhoA and Rac1 could regulate TJ gate and
fence functions via the actin cytoskeleton by altering the
forces that push cells together and/or the complexity of
strand organization. Madara (Madara et al., 1988) sug-
gested that TJ functions could be modified by contraction
of perijunctional actin filaments that could result in cen-
trifugal traction on TJ membrane contacts. Changes in ac-
tin contractility could subtly alter the distance between
parallel strands and/or between cross-bridges to modulate
fence function, and regulating centrifugal traction could
change the force pushing strands together on opposing cell
surfaces to modulate gate function. The actin cytoskeleton
is a target for RhoA and Rac1 activities (Hall, 1998). It is
possible that rapid cycling (flickering) of RhoA and Rac1
GTPases between GTP- and GDP-bound forms is re-
quired to fine-tune tension in the cortical actin belt, and
thereby modulate TJ structure to a specific gate and fence
function. That the permeability of epithelia can be con-
verted from tight to leaky under physiological conditions
(Madara, 1988; Madara, et al., 1986) and by expressing
RhoA or Rac1 mutants (this study) supports the view that
mechanisms involved in regulating TJ functions are dy-
namic.
The targets of RhoA and Rac1 that regulate TJ func-
tions will need to be identified. Although several targets
have identified in single motile cells, they too may be can-
didates for regulating TJ functions in epithelia. These can-
didates include downstream targets of Rho-kinase such as
myosin phosphatase and the regulatory myosin light chainThe Journal of Cell Biology, Volume 142, 1998 114
(Amano et al., 1996; Kimura et al., 1996), which control
the interaction of myosin with actin filaments and subse-
quent force generation, the ERM family of proteins (Mat-
sui et al., 1998), and phosphatidylinositol (4,5)-bisphos-
phate (PIP2) synthesis (Chong, et al., 1994) since PIP2 has
broad effects on the actin cytoskeleton (Janmey, 1994).
Whether RhoA and Rac1 have the same targets is also un-
known, although results reported in the accompanying
study indicate that Rac1 does not function through RhoA
in these cells (Jou and Nelson, 1998). The availability of
stable cell lines expressing RhoA and Rac1 mutant GTP-
ases should facilitate the identification of potential targets.
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